Kanabo Group PLC
LSE:KNB

Watchlist Manager
Kanabo Group PLC Logo
Kanabo Group PLC
LSE:KNB
Watchlist
Price: 0.225 GBX
Market Cap: 1.4m GBX

Kanabo Group PLC
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kanabo Group PLC
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Kanabo Group PLC
LSE:KNB
Change in Working Capital
-ÂŁ632k
CAGR 3-Years
-581%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Change in Working Capital
-ÂŁ3.1B
CAGR 3-Years
-82%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
AstraZeneca PLC
LSE:AZN
Change in Working Capital
-$4.6B
CAGR 3-Years
N/A
CAGR 5-Years
-19%
CAGR 10-Years
-17%
Verona Pharma PLC
NASDAQ:VRNA
Change in Working Capital
-$98.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Change in Working Capital
-$41m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Change in Working Capital
-$206m
CAGR 3-Years
-4%
CAGR 5-Years
-21%
CAGR 10-Years
-8%
No Stocks Found

Kanabo Group PLC
Glance View

Market Cap
1.4m GBX
Industry
Pharmaceuticals

Kanabo Group Plc engages in the acquisition of a target company and business in the energy and industrial sectors. The firm is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. The company has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod, which is a vaporization delivery system for cannabis extract. The firm's R&D lab is set up in the Weizmann Science Park. The firm's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The firm is selling its initial products in Europe. The company is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.

KNB Intrinsic Value
Not Available

See Also

What is Kanabo Group PLC's Change in Working Capital?
Change in Working Capital
-632k GBP

Based on the financial report for Dec 31, 2023, Kanabo Group PLC's Change in Working Capital amounts to -632k GBP.

What is Kanabo Group PLC's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-65%

The average annual Change in Working Capital growth rates for Kanabo Group PLC have been -581% over the past three years , -65% over the past five years .

Back to Top